Intuitive Surgical (ISRG) FY2025 10-K Annual Report
Intuitive Surgical (ISRG) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Feb 3, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
Intuitive Surgical FY2025 10-K Analysis
Business Overview
- • Core business: robotic-assisted minimally invasive surgical systems with integrated instruments, accessories, learning, and digital solutions
- • New product emphasis: launched da Vinci 5 system with force feedback, 10,000x computing power of Xi, and My Intuitive+ digital subscription package
Management Discussion & Analysis
- • Tariffs increased cost of revenues by $63.0M in 2025; ongoing tariff impact expected to rise in 2026
- • Installed base: 1,231 da Vinci 5 systems, 377 da Vinci SP systems as of Dec 31, 2025
Risk Factors
- • UK medical device regulatory changes, new post-market rules effective June 16, 2025, with additional rules expected in 2026 potentially delaying UK market approval
- • China anti-corruption campaign in healthcare since July 2023 causing tender cancellations, reducing system placements in 2025 versus expectations
Intuitive Surgical FY2025 Key Financial MetricsXBRL
Revenue
$10.1B
▲ +20.5% YoY
Net Income
$2.9B
▲ +23.0% YoY
Gross Margin
66.0%
▼ -146bp YoY
Operating Margin
29.3%
▲ +114bp YoY
Net Margin
28.4%
▲ +57bp YoY
ROE
16.0%
▲ +189bp YoY
Total Assets
$20.5B
▲ +9.2% YoY
EPS (Diluted)
$7.87
▲ +22.6% YoY
Operating Cash Flow
$3.0B
▲ +25.5% YoY
Source: XBRL data from Intuitive Surgical FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on Intuitive Surgical
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.